1. Home
  2. AIRE vs SYBX Comparison

AIRE vs SYBX Comparison

Compare AIRE & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIRE
  • SYBX
  • Stock Information
  • Founded
  • AIRE 2021
  • SYBX N/A
  • Country
  • AIRE United States
  • SYBX United States
  • Employees
  • AIRE N/A
  • SYBX N/A
  • Industry
  • AIRE
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIRE
  • SYBX Health Care
  • Exchange
  • AIRE Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • AIRE 13.7M
  • SYBX 16.4M
  • IPO Year
  • AIRE N/A
  • SYBX N/A
  • Fundamental
  • Price
  • AIRE $0.34
  • SYBX $1.38
  • Analyst Decision
  • AIRE Hold
  • SYBX
  • Analyst Count
  • AIRE 1
  • SYBX 0
  • Target Price
  • AIRE N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • AIRE 59.7M
  • SYBX 103.1K
  • Earning Date
  • AIRE 08-21-2025
  • SYBX 08-19-2025
  • Dividend Yield
  • AIRE N/A
  • SYBX N/A
  • EPS Growth
  • AIRE N/A
  • SYBX N/A
  • EPS
  • AIRE N/A
  • SYBX N/A
  • Revenue
  • AIRE $1,853,629.00
  • SYBX N/A
  • Revenue This Year
  • AIRE $369.52
  • SYBX N/A
  • Revenue Next Year
  • AIRE $68.67
  • SYBX N/A
  • P/E Ratio
  • AIRE N/A
  • SYBX N/A
  • Revenue Growth
  • AIRE 1925.60
  • SYBX N/A
  • 52 Week Low
  • AIRE $0.14
  • SYBX $0.90
  • 52 Week High
  • AIRE $4.49
  • SYBX $1.96
  • Technical
  • Relative Strength Index (RSI)
  • AIRE 47.75
  • SYBX 45.87
  • Support Level
  • AIRE $0.33
  • SYBX $1.33
  • Resistance Level
  • AIRE $0.37
  • SYBX $1.96
  • Average True Range (ATR)
  • AIRE 0.05
  • SYBX 0.11
  • MACD
  • AIRE -0.00
  • SYBX -0.03
  • Stochastic Oscillator
  • AIRE 6.12
  • SYBX 12.82

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: